KORRO BIO
Live / Applied — Fourth extension granted (statement of use) (as of 30 Dec 2025)
What this means for you
Not registered yet, but its 07 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97493218
- Mark type
- Stylized text
- Filed
- 07 Jul 2022
- Published for opposition
- 07 Nov 2023
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of biomedical compounds comprised of nucleotide polymers or biomedical compounds comprised of ribonucleic acid polymers for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders
Owner
- Korro Bio, Inc., Cambridge, MA, US
- Korro Bio, Inc., Cambridge, MA, US
Prosecution history
- 30 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Dec 2025 — SOU EXTENSION 4 GRANTED
- 21 Dec 2025 — SOU EXTENSION 4 FILED
- 22 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2025 — SOU EXTENSION 3 GRANTED
- 23 Jun 2025 — SOU EXTENSION 3 FILED
- 09 Jul 2025 — DIVISIONAL PROCESSING COMPLETE
- 24 Jun 2025 — DIVISIONAL REQUEST RECEIVED
- 24 Jun 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 24 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 03 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Apr 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Apr 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED